Ignacio Garrido-Laguna

No bio available.

Financial relationships

  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    BridgeBio Pharma , Genentech
    Topic: 
    Principal Investigatir
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Revolution Medicine
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Tango Therapeutics
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Sumitomo
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    ABM Therapeutics
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    BMS
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Novartis
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Bayer
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    GlaxoSmithKline
    Date added: 
    07/16/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Date added: 
    07/16/2023

Pages

Return to Colorado Hematology Oncology Conference: Emphasis on Precision-Guided Management